ArticleACS omega2025
A Straightforward Interpretation of Proximity Labeling through Direct Biotinylation Analysis.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- In Depth Characterization of the Promoter Proximal Proteome of Single Copy Locus FOXP2.Molecular & cellular proteomics : MCP · 2026Article
- Proximity labeling in neuroscience: decoding molecular landscapes for precision neurology.Translational neurodegeneration · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Proximity labeling (PL) is a revolutionary tool in proteomics, enabling the precise identification of protein interactions in live cells. However, conventional statistical approaches for analyzing biotinylation data often lead to false positives, hindering the accuracy of the PL studies. In this study, we propose a direct biotinylation analysis approach that focuses on identifying only biotinylated peptides rather than relying solely on statistical comparisons. Using LC-MS data from a prior TurboID-based study, we reanalyzed secretome data sets and demonstrated significant improvements in identifying true biotinylated proteins with fewer false positives. By applying this approach to tissue-specific secretome data, we identified fibronectin (FN1) as a pericyte-specific marker. Our findings highlight that the limitations of traditional methods are insufficiently robust, and we advocate for the adoption of direct biotinylation analysis to enhance data reliability in PL-based proteomics. This methodology sets a new standard for studying protein interactions and secretomes, offering deeper insights into cellular- and tissue-specific molecular networks.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.